Skip to main content

The Cooper Companies statistics

  • COO · Nasdaq
  • Medical devices
  • Health Care Supplies
  • S&P 500
$62.65+0.74%Close 13 Nov 2026 · Market value $11.91B · Next results 3 Dec 2026

Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.

Valuation

The Cooper Companies is valued at $11.91B on its latest close. Its price is 20.9 times its earnings.

Market value$11.91B
Enterprise value$14.30B
Price / earnings20.89
Price / sales2.81
Price / book1.43
EV / EBITDA15.41
EV / sales3.37
Price / free cash flow17.57
Price / free cash flow, own 5-year average55.41
EV / EBIT26.28
EV / free cash flow21.10
Free cash flow yield5.7%

Share price

Latest close$62.65
Day's change+0.7%
52-week high$89.83
52-week low$51.01
From 52-week high−30.3%
Return · 1 month+8.1%
Return · 3 months−17.7%
Return · year to date−23.6%
Return · 1 year−13.6%
Beta · 1 year against the S&P 5000.48
50-day average$58.49
200-day average$67.96
RSI 1456.6
Average volume · 20 sessions2.6M

Margins and returns

For fiscal 2025, as filed.

Gross margin65.5%
Operating margin16.7%
Net margin9.2%
Free cash flow margin10.6%
Return on equity4.6%
Return on assets3.7%
Return on invested capital4.0%
Return on invested capital, 5-year average4.3%
Return on capital employed6.1%
Stock-based compensation / revenue1.7%

Financial position

At the end of fiscal 2025.

Cash and equivalents$110.6M
Total debt$2.78B
Net debt$2.67B
Current ratio1.89
Quick ratio0.51
Debt / equity0.34
Net debt / EBITDA2.52
Interest coverage6.83

Growth

Revenue, latest quarter on a year+0.6%
Revenue, twelve months on a year+4.7%
EPS, latest quarter on a year+357%
EPS, twelve months on a year+43.3%
Revenue, 5-year compound+11.0%
Revenue, 10-year compound+8.6%
Net income, 5-year compound+9.5%
Free cash flow, 5-year compound+19.7%
EPS, 5-year compound+9.3%

Shares and dividends

For fiscal 2025, as filed.

Diluted shares200M
Shares outstanding, 5-year compound+0.2%
Net share repurchases$284.7M
Dividend payout0.0%

Taxes

For fiscal 2025, as filed.

Income tax expense$191.6M
Effective tax rate33.8%

COO in the terminal

Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.